pembrolizumab

Drug / Medication

A checkpoint inhibitor used in immunotherapy, particularly effective in triple-negative breast cancers.

Mentioned in 3 videos

Videos Mentioning pembrolizumab

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

Peter Attia MD

A checkpoint inhibitor that shows clear survival benefits in specific oncology settings, but has also been disappointing in others, making its effectiveness case-by-case.

278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.

278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.

Peter Attia MD

A checkpoint inhibitor used in immunotherapy, particularly effective in triple-negative breast cancers.

Journal Club with Dr. Peter Attia | Effects of Light & Dark on Mental Health & Treatments for Cancer

Journal Club with Dr. Peter Attia | Effects of Light & Dark on Mental Health & Treatments for Cancer

Andrew Huberman

An anti-PD-1 drug that emerged after Ipilimumab, showing greater response rates and overall survival in metastatic melanoma, famously used to cure a friend's pancreatic cancer.